glp-1 inno supps INNOSUPPS Trim Biome – TrustScore® 8.0/10 InnoSupps Inno Shred GLP-1 -
Description
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Rosenstock, M
Golla R
Most of the current data come from retrospective or observational research
References [1] Teigen LM, Biruete A, Khoruts A
Erythromycin antagonises the deceleration of gastric emptying by glucagon-like peptide 1 (GLP-1) and unmasks its insulinotropic effect in healthy subjects
